A Crowd Sourcing Platform for Patients With Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03530826 |
|
Recruitment Status :
Recruiting
First Posted : May 21, 2018
Last Update Posted : July 21, 2021
|
Sponsor:
All4Cure
Information provided by (Responsible Party):
Carl Anthony Blau, MD, All4Cure
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Submitted Date | May 7, 2018 | ||||||||
| First Posted Date | May 21, 2018 | ||||||||
| Last Update Posted Date | July 21, 2021 | ||||||||
| Actual Study Start Date | April 26, 2018 | ||||||||
| Estimated Primary Completion Date | January 31, 2028 (Final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures |
Change in tumor tissue molecular profiles [ Time Frame: 6 years ] Profiles of pre- and post-treatment tumor tissue will be compared.
|
||||||||
| Original Primary Outcome Measures | Same as current | ||||||||
| Change History | |||||||||
| Current Secondary Outcome Measures | Not Provided | ||||||||
| Original Secondary Outcome Measures | Not Provided | ||||||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title | A Crowd Sourcing Platform for Patients With Cancer | ||||||||
| Official Title | A Crowd Sourcing Platform for Patients With Cancer | ||||||||
| Brief Summary | All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster. | ||||||||
| Detailed Description | The core hypothesis tested by this study is that engaging researchers, clinicians and patients in an online knowledge sharing platform will enable patients to better understand cancer, better inform treatment decisions made by oncologists and accelerate cancer research. Leftover samples from patients with cancer (blood, bodily fluids and/or tissues collected for clinical purposes) will be obtained and sent for various types of analyses and results will be shared on the All4Cure website. | ||||||||
| Study Type | Observational [Patient Registry] | ||||||||
| Study Design | Observational Model: Other Time Perspective: Prospective |
||||||||
| Target Follow-Up Duration | 10 Years | ||||||||
| Biospecimen | Not Provided | ||||||||
| Sampling Method | Non-Probability Sample | ||||||||
| Study Population | Adult cancer patients | ||||||||
| Condition | Cancer | ||||||||
| Intervention | Other: No intervention
No Intervention
|
||||||||
| Study Groups/Cohorts | Not Provided | ||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status | Recruiting | ||||||||
| Estimated Enrollment |
5000 | ||||||||
| Original Estimated Enrollment | Same as current | ||||||||
| Estimated Study Completion Date | January 31, 2028 | ||||||||
| Estimated Primary Completion Date | January 31, 2028 (Final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria: |
||||||||
| Sex/Gender |
|
||||||||
| Ages | 18 Years and older (Adult, Older Adult) | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts |
|
||||||||
| Listed Location Countries | United States | ||||||||
| Removed Location Countries | |||||||||
| Administrative Information | |||||||||
| NCT Number | NCT03530826 | ||||||||
| Other Study ID Numbers | All4Cure01 | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| U.S. FDA-regulated Product |
|
||||||||
| IPD Sharing Statement |
|
||||||||
| Current Responsible Party | Carl Anthony Blau, MD, All4Cure | ||||||||
| Original Responsible Party | Same as current | ||||||||
| Current Study Sponsor | All4Cure | ||||||||
| Original Study Sponsor | Same as current | ||||||||
| Collaborators | Not Provided | ||||||||
| Investigators |
|
||||||||
| PRS Account | All4Cure | ||||||||
| Verification Date | July 2021 | ||||||||